3 Big Pharma Stocks Set to Succeed
That disclaimer that the Securities and Exchange Commission requires mutual funds to provide to investors isn't one to overlook: Past performance really may not be indicative of future results. This applies to mutual funds and to individual stocks.
For big pharma stocks, though, you can get a sense for what their prospects could look like. Current products and pipeline candidates can help investors determine which stocks have the best chances at being winners. In my view, three big pharma stocks look set to succeed: AbbVie (NYSE: ABBV), Allergan (NYSE: AGN), and Celgene (NASDAQ: CELG). Here's why.
Image source: Getty Images.
Source: Fool.com
Amgen Inc. Stock
€307.20
-0.440%
The stock is an absolute favorite of our community with 25 Buy predictions and no Sell predictions.
On the other hand, the target price of 304 € is below the current price of 307.2 € for Amgen Inc., so the potential is actually -1.04%.
